Concepedia

Lijuan Dai

LD

Statistics

Publications

4

Citations

78

H-Index

4

Active since

2017

Affiliations

First Affiliated Hospital of Heilongjiang University of Chinese Medicine(Current)

Heilongjiang University of Chinese Medicine

Shantou University Medical College

Shantou University

Lijuan Dai is an author at First Affiliated Hospital of Heilongjiang University of Chinese Medicine specializing in oncology, life sciences, and extracellular signal-regulated kinase signaling.

ORCID

Publications per year

2017–2021

4

Publications

4

Circ-ACTR2 aggravates the high glucose-induced cell dysfunction of human renal mesangial cells through mediating the miR-205-5p/HMGA2 axis in diabetic nephropathy

Jie Yun, Jinyu Ren, Yufei Liu et al. · Diabetology & Metabolic Syndrome · 2021 · 30 citations · Full text

, , +17

Extracellular signal-regulated kinase 8-mediated NF-κB activation increases sensitivity of human lung cancer cells to arsenic trioxide

Dandan Wu, Andy T. Y. Lau, Fei‐Yuan Yu et al. · Oncotarget · 2017 · 25 citations · Full text

, , +15

MicroRNA (miR)-590-3p alleviates high-glucose induced renal tubular epithelial cell damage by targeting C-X3-C motif chemokine ligand 1 (CX3CL1) in diabetic nephropathy

Jie Yun, Jinyu Ren, Yufei Liu et al. · Bioengineered · 2021 · 12 citations · Full text

, , +17

Purification and characterization of a highly specific polyclonal antibody against human extracellular signal-regulated kinase 8 and its detection in lung cancer

Na‐Li Cai, Andy T. Y. Lau, Fei‐Yuan Yu et al. · PLoS ONE · 2017 · 11 citations · Full text

, , +15

1–4 of 4